Collection Details : Hepatology

Secondary Logo

Journal Logo

Graphical Abstracts

  • Updated:   3/20/2023
  • Contains:  122 items

Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C, or nonalcoholic steatohepatitis

Loureiro, Dimitri; Tout, Issam; Narguet, Stéphanie; More

Hepatology. 77(4):1348-1365, April 2023.

RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease

Afonso, Marta B.; Islam, Tawhidul; Magusto, Julie; More

Hepatology. 77(4):1319-1334, April 2023.

Essential lipid autacoids rewire mitochondrial energy efficiency in metabolic dysfunction‐associated fatty liver disease

López‐Vicario, Cristina; Sebastián, David; Casulleras, Mireia; More

Hepatology. 77(4):1303-1318, April 2023.

Essential lipid autacoids rewire mitochondrial energy efficiency in metabolic dysfunction‐associated fatty liver disease

López‐Vicario, Cristina; Sebastián, David; Casulleras, Mireia; More

Hepatology. 77(4):1303-1318, April 2023.

Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride‐rich lipoprotein metabolism

Deprince, Audrey; Hennuyer, Nathalie; Kooijman, Sander; More

Hepatology. 77(4):1287-1302, April 2023.

Serum FGF19 predicts outcomes of Kasai portoenterostomy in biliary atresia

Nyholm, Iiris; Hukkinen, Maria; Pihlajoki, Marjut; More

Hepatology. 77(4):1263-1273, April 2023.

Multicentered study of patient outcomes after declined for early liver transplantation in severe alcohol-associated hepatitis

Hsu, Christine C.; Dodge, Jennifer L.; Weinberg, Ethan; More

Hepatology. 77(4):1253-1262, April 2023.

Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis

Torres, Sandra; Ortiz, Cristina; Bachtler, Nadine; More

Hepatology. 77(4):1228-1240, April 2023.

ALK1 controls hepatic vessel formation, angiodiversity, and angiocrine functions in hereditary hemorrhagic telangiectasia of the liver

Schmid, Christian David; Olsavszky, Victor; Reinhart, Manuel; More

Hepatology. 77(4):1211-1227, April 2023.

Probiotic‐derived nanoparticles inhibit ALD through intestinal miR194 suppression and subsequent FXR activation

Jiang, Mengwei; Li, Fengyuan; Liu, Yunhuan; More

Hepatology. 77(4):1164-1180, April 2023.

Eliminating METTL1‐mediated accumulation of PMN‐MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation

Zeng, Xuezhen; Liao, Guanrui; Li, Shumin; More

Hepatology. 77(4):1122-1138, April 2023.

Malignant progression of liver cancer progenitors requires lysine acetyltransferase 7–acetylated and cytoplasm‐translocated G protein GαS

Zhou, Ye; Jia, Kaiwei; Wang, Suyuan; More

Hepatology. 77(4):1106-1121, April 2023.

Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration

Díaz-González, Álvaro; Hernández-Guerra, Manuel; Pérez-Medrano, Indhira; More

Hepatology. 77(4):1095-1105, April 2023.

Identification of novel neutralizing determinants for protection against HCV

Alzua, Garazi P.; Pihl, Anne F.; Offersgaard, Anna; More

Hepatology. 77(3):982-996, March 2023.

Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD

Canivet, Clémence M.; Costentin, Charlotte; Irvine, Katharina M.; More

Hepatology. 77(3):920-930, March 2023.

Macrophage‐derived MLKL in alcohol‐associated liver disease: Regulation of phagocytosis

Wu, Xiaoqin; Fan, Xiude; McMullen, Megan R.; More

Hepatology. 77(3):902-919, March 2023.

Lipocalin‐2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high‐fat diet–fed Ob/Ob mice

Kim, Kyung Eun; Lee, Jaewoong; Shin, Hyun Joo; More

Hepatology. 77(3):888-901, March 2023.

Myeloid p38 activation maintains macrophage–liver crosstalk and BAT thermogenesis through IL‐12–FGF21 axis

Crespo, María; Nikolic, Ivana; Mora, Alfonso; More

Hepatology. 77(3):874-887, March 2023.

Serum bile acids as a prognostic biomarker in biliary atresia following Kasai portoenterostomy

Harpavat, Sanjiv; Hawthorne, Kieran; Setchell, Kenneth D. R.; More

Hepatology. 77(3):862-873, March 2023.

Adeno‐associated virus serotype 2 capsid variants for improved liver‐directed gene therapy

Meumann, Nadja; Cabanes‐Creus, Marti; Ertelt, Moritz; More

Hepatology. 77(3):802-815, March 2023.

HCC EV ECG score: An extracellular vesicle‐based protein assay for detection of early‐stage hepatocellular carcinoma

Sun, Na; Zhang, Ceng; Lee, Yi‐Te; More

Hepatology. 77(3):774-788, March 2023.

Silmitasertib plus gemcitabine and cisplatin first‐line therapy in locally advanced/metastatic cholangiocarcinoma: A Phase 1b/2 study

Borad, Mitesh J.; Bai, Li‐Yuan; Richards, Donald; More

Hepatology. 77(3):760-773, March 2023.

Ten‐eleven translocation‐2 inactivation restrains IL‐10‐producing regulatory B cells to enable antitumor immunity in hepatocellular carcinoma

Lu, Zhou; Liu, Ronghua; Wang, Yining; More

Hepatology. 77(3):745-759, March 2023.

Polo‐like kinase 4 inhibitor CFI‐400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunity

Chan, Cerise Yuen‐Ki; Yuen, Vincent Wai‐Hin; Chiu, David Kung‐Chun; More

Hepatology. 77(3):729-744, March 2023.

A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation

Hole, Mikal Jacob; Jørgensen, Kristin Kaasen; Holm, Kristian; More

Hepatology. 77(3):715-728, March 2023.

HBV transcription and translation persist despite viral suppression in HBV‐HIV co‐infected patients on antiretroviral therapy

Lisker‐Melman, Mauricio; Wahed, Abdus S.; Ghany, Marc G.; More

Hepatology. 77(2):594-605, February 2023.

Age and the relative importance of liver‐related deaths in nonalcoholic fatty liver disease

Lin, Huapeng; Yip, Terry Cheuk‐Fung; Zhang, Xinrong; More

Hepatology. 77(2):573-584, February 2023.

Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness

Indira Chandran, Vineesh; Wernberg, Charlotte Wilhelmina; Lauridsen, Mette Munk; More

Hepatology. 77(2):558-572, February 2023.

Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD‐related cirrhosis

Chang, Devon; Truong, Emily; Mena, Edward A.; More

Hepatology. 77(2):546-557, February 2023.

Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease

Leung, Daniel H.; Devaraj, Sridevi; Goodrich, Nathan P.; More

Hepatology. 77(2):530-545, February 2023.

Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study

Vandriel, Shannon M.; Li, Li‐Ting; She, Huiyu; More

Hepatology. 77(2):512-529, February 2023.

Genetic predisposition to porto‐sinusoidal vascular disorder: A functional genomic‐based, multigenerational family study

Shan, Jingxuan; Megarbane, André; Chouchane, Aziz; More

Hepatology. 77(2):501-511, February 2023.

Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model

Vizzutti, Francesco; Celsa, Ciro; Calvaruso, Vincenza; More

Hepatology. 77(2):476-488, February 2023.

Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS

Queck, Alexander; Schwierz, Louise; Gu, Wenyi; More

Hepatology. 77(2):466-475, February 2023.

Characterization and role of collagen gene expressing hepatic cells following partial hepatectomy in mice

Kimura, Yusuke; Koyama, Yukinori; Taura, Kojiro; More

Hepatology. 77(2):443-455, February 2023.

Body weight changes and duration of estrogen exposure modulate the evolution of hepatocellular adenomas after contraception discontinuation

Demory, Alix; Péron, Jean‐Marie; Calderaro, Julien; More

Hepatology. 77(2):430-442, February 2023.

TNF receptor–related factor 3 inactivation promotes the development of intrahepatic cholangiocarcinoma through NF‐κB‐inducing kinase–mediated hepatocyte transdifferentiation

Shiode, Yuto; Kodama, Takahiro; Shigeno, Satoshi; More

Hepatology. 77(2):395-410, February 2023.

Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLD

Smirnova, Ekaterina; Muthiah, Mark D.; Narayan, Nicole; More

Hepatology. 76(6):1811-1824, December 2022.

Hepatocellular cystathionine γ lyase/hydrogen sulfide attenuates nonalcoholic fatty liver disease by activating farnesoid X receptor

Xu, Wenjing; Cui, Changting; Cui, Chunmei; More

Hepatology. 76(6):1794-1810, December 2022.

Impact of bacterial infections and spontaneous bacterial peritonitis prophylaxis on phage‐bacterial dynamics in cirrhosis

Bajaj, Jasmohan S.; Rodriguez, Marcela Peňa; Fagan, Andrew; More

Hepatology. 76(6):1723-1734, December 2022.

C‐C motif chemokine ligand 5 confines liver regeneration by down‐regulating reparative macrophage‐derived hepatocyte growth factor in a forkhead box O 3a–dependent manner

Huang, Miao; Jiao, Junzhe; Cai, Hao; More

Hepatology. 76(6):1706-1722, December 2022.

Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United States

Ahn, Joseph C.; Lauzon, Marie; Luu, Michael; More

Hepatology. 76(6):1649-1659, December 2022.

Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes

Lee, Sung Hwan; Yim, Sun Young; Jeong, Yun Seong; More

Hepatology. 76(6):1634-1648, December 2022.

Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids

Ruiz de Gauna, Mikel; Biancaniello, Francesca; González‐Romero, Francisco; More

Hepatology. 76(6):1617-1633, December 2022.

Liver injury after SARS‐CoV‐2 vaccination: Features of immune‐mediated hepatitis, role of corticosteroid therapy and outcome

Efe, Cumali; Kulkarni, Anand V.; Terziroli Beretta‐Piccoli, Benedetta; More

Hepatology. 76(6):1576-1586, December 2022.

Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID‐19 in patients with chronic liver disease

Hartl, Lukas; Haslinger, Katharina; Angerer, Martin; More

Hepatology. 76(6):1563-1575, December 2022.

Discovery of an insulin‐induced gene binding compound that ameliorates nonalcoholic steatohepatitis by inhibiting sterol regulatory element‐binding protein–mediated lipogenesis

Jiang, Shi‐You; Yang, Xinglin; Yang, Zimo; More

Hepatology. 76(5):1466-1481, November 2022.

Risk of liver‐related events by age and diabetes duration in patients with diabetes and nonalcoholic fatty liver disease

Zhang, Xinrong; Wong, Grace Lai‐Hung; Yip, Terry Cheuk‐Fung; More

Hepatology. 76(5):1409-1422, November 2022.